SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-002535
Filing Date
2008-04-15
Accepted
2008-04-15 17:20:10
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPOROATION b69133rpe10vk.htm 10-K 1251819
2 EX-14.1 CODE OF CONDUCT b69133rpexv14w1.htm EX-14.1 58176
3 EX-31.1 SECTION 302 CERTIFICATION OF PEO b69133rpexv31w1.htm EX-31.1 4708
4 EX-31.2 SECTION 302 CERTIFICATION OF PFO b69133rpexv31w2.htm EX-31.2 4730
5 EX-32.1 SECTION 906 CERTIFICATION OF PEO & PFO b69133rpexv32w1.htm EX-32.1 2357
6 GRAPHIC b69133rpb6913301.gif GRAPHIC 9771
7 GRAPHIC b69133rpb6913302.gif GRAPHIC 3195
8 GRAPHIC b69133rpb6913303.gif GRAPHIC 13458
9 GRAPHIC b69133rpb6913304.gif GRAPHIC 13697
  Complete submission text file 0000950135-08-002535.txt   1379016
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 08758106
SIC: 2834 Pharmaceutical Preparations